Raoof et al reported the MEGNA score for evaluating patients with intrahepatic cholangiocarcinoma. This can help to stage the patient's disease and to predict survival. The authors are from City of Hope National Medical Center in Duarte, California.
Patient selection: intrahepatic cholangiocarcinoma
Parameters:
(1) multifocality (M)
(2) extrahepatic extension (E)
(3) high grade (G)
(4) lymph node positive for malignancy (N)
(5) age > 60 years (A)
1 point was assigned for each finding if present.
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 5
MEGNA Score
5-Year Survival
0
62%
1
29%
2
14%
>=3
0%
from Figure 2
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology, Gastroenterology
